115 related articles for article (PubMed ID: 38401853)
1. Engineered PDGFA-ligand-modified exosomes delivery T3 for demyelinating disease targeted therapy.
Wang LB; Liao BY; Li YJ; Wang ZH; Yu Y; Li X; Zhang QH
Exp Neurol; 2024 May; 375():114730. PubMed ID: 38401853
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of bryostatin-1 by targeted exosomes enhances remyelination and neuroprotection effects in the cuprizone-induced demyelinating animal model of multiple sclerosis.
Wu XY; Liao BY; Xiao D; Wu WC; Xiao Y; Alexander T; Song SJ; Zhao ZH; Zhang Y; Wang ZH; Wang LB; Li X
Biomater Sci; 2022 Feb; 10(3):714-727. PubMed ID: 34928285
[TBL] [Abstract][Full Text] [Related]
3. A targeted extracellular vesicles loaded with montelukast in the treatment of demyelinating diseases.
Xiao Y; Zhang Y; Gao YH; Zhao ZH; He J; Gao R; Guo YX; Wang LB; Li X
Biochem Biophys Res Commun; 2022 Feb; 594():31-37. PubMed ID: 35066377
[TBL] [Abstract][Full Text] [Related]
4. Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.
Zendedel A; Kashani IR; Azimzadeh M; Pasbakhsh P; Omidi N; Golestani A; Beyer C; Clarner T
Metab Brain Dis; 2016 Apr; 31(2):425-33. PubMed ID: 26725831
[TBL] [Abstract][Full Text] [Related]
5. Exosome-specific loading Sox10 for the treatment of Cuprizone-induced demyelinating model.
He J; Wang Y; Zhao ZH; He JY; Gao MY; Wang JQ; Wang LB; Zhang Y; Li X
Biomed Pharmacother; 2024 Feb; 171():116128. PubMed ID: 38218078
[TBL] [Abstract][Full Text] [Related]
6. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
7. A new model of cuprizone-mediated demyelination/remyelination.
Sachs HH; Bercury KK; Popescu DC; Narayanan SP; Macklin WB
ASN Neuro; 2014; 6(5):. PubMed ID: 25290063
[TBL] [Abstract][Full Text] [Related]
8. 24-hydroxycholesterol replacement rate measured in blood is a non-invasive biomarker of brain demyelination and remyelination in cuprizone-treated mice.
Shankaran M; Mohammed H; Tsang E; Wong PA; Protasio J; Murphy EJ; Bernard F; Chang R; Dellovade T; Turner S; Hellerstein MK
Exp Neurol; 2023 Jun; 364():114395. PubMed ID: 37003487
[TBL] [Abstract][Full Text] [Related]
9. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
[TBL] [Abstract][Full Text] [Related]
10. Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.
Ding ZB; Han QX; Wang Q; Song LJ; Chu GG; Guo MF; Chai Z; Yu JZ; Xiao BG; Li XY; Ma CG
Neurosci Lett; 2021 May; 753():135880. PubMed ID: 33838256
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
12. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
[TBL] [Abstract][Full Text] [Related]
13. Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination.
Yano R; Hata J; Abe Y; Seki F; Yoshida K; Komaki Y; Okano H; Tanaka KF
Neurochem Int; 2018 Oct; 119():151-158. PubMed ID: 29030079
[TBL] [Abstract][Full Text] [Related]
14. Investigation of sequential growth factor delivery during cuprizone challenge in mice aimed to enhance oligodendrogliogenesis and myelin repair.
Sabo JK; Aumann TD; Kilpatrick TJ; Cate HS
PLoS One; 2013; 8(5):e63415. PubMed ID: 23650566
[TBL] [Abstract][Full Text] [Related]
15. Conditional Deletion of Foxg1 Alleviates Demyelination and Facilitates Remyelination via the Wnt Signaling Pathway in Cuprizone-Induced Demyelinated Mice.
Dong F; Liu D; Jiang F; Liu Y; Wu X; Qu X; Liu J; Chen Y; Fan H; Yao R
Neurosci Bull; 2021 Jan; 37(1):15-30. PubMed ID: 33015737
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination.
Crocker SJ; Bajpai R; Moore CS; Frausto RF; Brown GD; Pagarigan RR; Whitton JL; Terskikh AV
Neuropathol Appl Neurobiol; 2011 Oct; 37(6):643-53. PubMed ID: 21276029
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SUMOylation promotes remyelination and reduces IL-17 mediated autoimmune inflammation: Novel approach toward treatment of inflammatory CNS demyelinating disease.
Kim KW; Ljunggren-Rose Å; Matta P; Toki S; Sriram S
J Neuroimmunol; 2023 Nov; 384():578219. PubMed ID: 37813042
[TBL] [Abstract][Full Text] [Related]
18. Dendrosomal nanocurcumin promotes remyelination through induction of oligodendrogenesis in experimental demyelination animal model.
Motavaf M; Sadeghizadeh M; Babashah S; Zare L; Javan M
J Tissue Eng Regen Med; 2020 Oct; 14(10):1449-1464. PubMed ID: 32750189
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the Genetic Crosstalk between Microglia and Oligodendrocyte Precursor Cells during Demyelination and Remyelination Using Transcriptomic Data.
Enrich-Bengoa J; Manich G; Dégano IR; Perálvarez-Marín A
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499195
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.
Franco PG; Silvestroff L; Soto EF; Pasquini JM
Exp Neurol; 2008 Aug; 212(2):458-67. PubMed ID: 18572165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
